6 employees
Yukin Therapeutics specializes in the development of new molecules for the treatment of cancer.
2018
$3.7M
from 2 investors over 2 rounds
YUKIN THERAPEUTICS raised $3.7M on June 4, 2019
Investors: AdBio partners and Medicxi